HOME >> BIOLOGY >> NEWS
Dana-Farber launches Center for Applied Cancer Science

BOSTON--Dana-Farber Cancer Institute officials today announced the establishment of the Center for Applied Cancer Science, a far-reaching initiative designed to convert basic molecular discoveries into new therapies for cancer. The center is an integral part of Dana-Farber's strategic plan, which commits the Institute to making major advances in the development of cancer cures by accelerating the translation of scientific advances into novel cancer prevention methods, diagnostic techniques, and therapies.

"Dana-Farber has both the intellectual resources and the responsibility to overcome some of the traditional barriers that have slowed the discovery and development of new cancer therapies," says Dana-Farber President Edward J. Benz, Jr., MD. "Working alongside and with the pharmaceutical and biotechnology industries, we will further improve our academic-corporate collaborations that can, and ultimately will, save lives by translating scientific discoveries into novel highly effective therapies."

Under the direction of Ronald A. DePinho, MD, the American Cancer Society Research Professor at Dana-Farber and Harvard Medical School, the center's multidisciplinary teams of scientists, project managers and technology experts -- including molecular biologists, cancer geneticists, immunologists, bioinformatic specialists and clinical investigators -- will utilize large scale, high-resolution methods to discover cancer genes and then use the genes' unique features to devise specific drugs or antibodies to target them. The center will also harness the intellectual and technological capabilities of the broader Harvard community as well as establishing more productive working relationships with scientists in the biotech and pharmaceutical industries.

The center will build on Dana-Farber's expertise in developing mouse models of human cancer to facilitate the development of diagnostic tests for early cancer detection, and to reduce the time it takes to t
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
30-Mar-2004


Page: 1 2

Related biology news :

1. Kinase backgrounder: Iressa discovery part of major kinase project at Dana-Farber
2. Dana-Farber scientists discover natural blocker of HIV-1 virus
3. Dana-Farber researchers to lead collaborative smallpox studies
4. Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering
5. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
6. Joslin Diabetes Center launches research section on developmental and stem cell biology
7. NIH launches first center in Nationwide Chemical Genomics Network
8. Biogeosciences.org launches
9. Clemson launches S.C. DNA Learning Center
10. STN International launches Derwent World Patents Index First View
11. JGI launches community sequencing program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/12/2019)... ... March 12, 2019 , ... FEITIAN Technologies US ... smart cards, announced today the launch of two new payment card types which ... CVV Payment cards. These advanced technologies will help all elements of the payment ...
(Date:3/9/2019)... ... March 07, 2019 , ... A firm believer in causes greater than ... Society (LLS). This donation will help fund not only research to find a cure, ... , “We are always on the lookout for ways to make a difference. When ...
(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio announces the launch ... for scientists studying GPCR and DREADD signalling. Hello Bio has been granted a ... Neurological Disorders and Stroke, both institutes of the National Institutes of Health, as ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... N.J. (PRWEB) , ... March 14, 2019 , ... The ... create challenges for companies to keep up. Traditional Regulatory intelligence (RI) ... and adapting technology to get global Regulatory teams right Insights faster and cheaper. With ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... that its Canadian partner, the Eye Machine Canada Inc., had been given approval ... technology for treating Age-Related Macular Degeneration (AMD). , The previous month, the medical ...
(Date:3/14/2019)... ... March 13, 2019 , ... The International ... Conference , taking place in Brussels, Belgium on 25–26 September 2019. This event ... solutions, and innovative approaches. , “Biopharmaceuticals have become a main pillar in ...
(Date:3/12/2019)... , ... March 11, 2019 , ... ... hospital system in Colorado, and among the first in the nation, to offer ... lab draws, IV placement and overall degree to which staff showed compassion jumped ...
Breaking Biology Technology:
Cached News: